Acupuncture for the reduction of paroxysmal atrial fibrillation duration: a randomized controlled clinical trial

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•?Symptomatic paroxysmal atrial fibrillation with at least 2 episodes in the past 6 months and at least 1 episode confirmed by ECG.
•?No age limit, male or female.
•?No acupuncture treatment within the previous 6 month.
•?Cooperating with 8 weeks treatment and follow-up.
•?Signed written informed consent.

•Patients were excluded if they had any of the following
•?Secondary atrial fibrillation.
•?Catheter ablation or cardiac surgery within the last 3 months.
•?Severe heart failure (New York Heart Association (NYHA)III or IV).
•?In the absence of a pacemaker, patients with sick sinus syndrome, II or III degree atrioventricular block.
•?Echocardiography: left ventricular ejection fraction <35%, left atrium diameter >5.5cm.
•?Have severe lung, liver, kidney disease or other serious primary disease.
•?Skin allergy to ECG monitoring electrodes.
•?Patients enrolled in other clinical trials within the last 1 month.
•?Patients enrolled in other clinical trials within the last 3 months.

发起方

Beijing University of Chinese Medicine